Petros Pharmaceuticals Inc (PTPI)
0.6401
-0.04
(-5.88%)
USD |
NASDAQ |
Apr 24, 15:48
Petros Pharmaceuticals Debt to Equity Ratio: 0.6421 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6421 |
| September 30, 2023 | 1.189 |
| June 30, 2023 | 0.6765 |
| March 31, 2023 | 0.5904 |
| December 31, 2022 | 0.5674 |
| September 30, 2022 | 0.4669 |
| June 30, 2022 | 0.293 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.2856 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0975 |
| June 30, 2021 | 0.1757 |
| March 31, 2021 | 0.2419 |
| December 31, 2020 | 0.4107 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
1.189
Maximum
Sep 2023
0.4336
Average
0.4107
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Avalo Therapeutics Inc | 0.00 |
| Spectral AI Inc | 0.4341 |
| Imunon Inc | -- |
| Assembly Biosciences Inc | 0.00 |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 33.80M |
| Total Liabilities (Quarterly) | 21.32M |
| Shareholders Equity (Quarterly) | 12.48M |
| Current Ratio | 1.893 |
| Net Debt Paydown Yield | 7.82% |